Theme
Biotech '26: Scalable Oncology Drugs☆
ACLX-27.47%8.3%
BBOT-72.35%8.3%
BMY+33.35%8.3%
CMPX-75.84%8.3%
GMAB+13.19%8.3%
JAZZ+61.02%8.3%
KURA+2.63%8.3%
LEGN-41.93%8.3%
NRIX+104.51%8.3%
NUVL0.00%8.3%
RVMD+295.09%8.3%
ZYME+49.29%8.3%
As of Oct 9, 2026, 4:27 AM ET
Biotech '26: Scalable Oncology Drugs Constituents
Arcellx, Inc.ACLX | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | -1.67% | 0.00% | -4.64% | -27.47% | -20.70% | 281.61% | $3.75B |
BridgeBio Oncology Therapeutics Inc.BBOT | 8.3% | -0.58% | -10.24% | -49.37% | -13.20% | -72.68% | -65.90% | -65.80% | -72.35% | -65.80% | -65.80% | $274.0M |
Bristol-Myers Squibb CompanyBMY | 8.3% | -0.20% | -5.77% | -7.50% | -2.05% | 10.46% | -4.47% | 1.05% | 33.35% | 14.78% | 18.01% | $121.70B |
Compass Therapeutics, Inc.CMPX | 8.3% | -3.59% | -11.41% | -54.89% | 9.13% | -81.69% | -82.59% | -41.81% | -75.84% | -43.16% | -71.08% | $177.1M |
Genmab A/SGMAB | 8.3% | -1.64% | 1.95% | 9.11% | 4.34% | 17.05% | 22.45% | 91.55% | 13.19% | 52.82% | -15.97% | $22.13B |
Jazz Pharmaceuticals plcJAZZ | 8.3% | -3.78% | -6.64% | -7.82% | -4.53% | 30.85% | 17.07% | 75.93% | 61.02% | 106.70% | 63.60% | $13.97B |
Kura Oncology, Inc.KURA | 8.3% | -1.41% | -0.85% | -12.99% | -1.22% | 1.25% | 20.50% | 61.35% | 2.63% | -42.07% | -43.77% | $933.9M |
Legend Biotech CorporationLEGN | 8.3% | -2.14% | 0.48% | -6.03% | -3.16% | -13.94% | -1.53% | -43.71% | -41.93% | -61.07% | -65.05% | $3.46B |
Nurix Therapeutics, Inc.NRIX | 8.3% | -2.29% | -6.17% | -15.42% | -4.84% | 17.08% | 39.07% | 95.17% | 104.51% | 0.95% | -19.41% | $2.30B |
Nuvalent, Inc.NUVL | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 21.01% | $1.62B |
Revolution Medicines, Inc.RVMD | 8.3% | -6.35% | -6.75% | -9.42% | -8.63% | 136.18% | 84.40% | 443.70% | 295.09% | 277.98% | 577.18% | $39.99B |
Zymeworks Inc.ZYME | 8.3% | -4.79% | -6.86% | -6.96% | -2.70% | -4.06% | 8.46% | 111.91% | 49.29% | 101.60% | 2.72% | $1.86B |
| Theme return | — | -2.23% | -4.36% | -16.77% | -1.41% | -0.57% | 0.57% | 50.86% | 16.90% | 28.72% | 78.21% | — |
| Average | 8.3% | -2.23% | -4.36% | -13.44% | -2.24% | 3.24% | 3.12% | 60.39% | 28.46% | 26.84% | 56.92% | $17.68B |
| Median | 8.3% | -1.89% | -5.97% | -7.66% | -2.37% | 0.63% | 4.23% | 31.20% | 7.91% | 0.48% | -6.62% | $2.88B |
| Std Dev | 0.0% | 1.95% | 4.28% | 18.40% | 5.46% | 51.83% | 41.84% | 129.30% | 95.41% | 93.75% | 181.32% | $33.40B |
| Min | 8.3% | -6.35% | -11.41% | -54.89% | -13.20% | -81.69% | -82.59% | -65.80% | -75.84% | -65.80% | -71.08% | $177.1M |
| Max | 8.3% | 0.00% | 1.95% | 9.11% | 9.13% | 136.18% | 84.40% | 443.70% | 295.09% | 277.98% | 577.18% | $121.70B |
| % Positive Tickers | 0.00% | 16.67% | 8.33% | 16.67% | 50.00% | 50.00% | 58.33% | 58.33% | 50.00% | 50.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort